Successive positron emission tomography measurement of cerebral blood flow and neuroreceptors in the human brain: an 11C-SA4503 study

  • Kiichi Ishiwata
  • Kenji Ishii
  • Yuichi Kimura
  • Kazunori Kawamura
  • Keiichi Oda
  • Toru Sasaki
  • Muneyuki Sakata
  • Michio Senda
Original Article


For evaluating a newly developed radioligand for positron emission tomography (PET), successive measurements of regional cerebral blood flow (rCBF) and the kinetics of the radioligand in the same subject are preferable in the first clinical trial. In this study, we demonstrate an example for the study of 11C-labeled 1-(3,4-dimethoxyphenethyl)-4-(3-phenylprophyl) piperazine (11C-SA4503) for mapping sigma1 receptors in the human brain. Five healthy male subjects underwent two successive PET scans with 15O-H2O to measure the rCBF and with 11C-SA4503 (dynamic 60-min scan). The brain kinetics of 11C-SA4503 was evaluated using the time-activity curve (TAC) of tissue in each of the 11 regions of the brain and the metabolite-corrected TAC of plasma on the basis of a two-tissue compartment fourparameter model. The estimated parameters were four rate constants: K1, influx from plasma to brain tissue; k2, efflux from tissue to plasma; k3, association between tracer and receptors; and k4, dissociation of tracer-receptor complex, and the binding potential (BP), k3/k4. 11CSA4503 was distributed all over the brain, and the TACs exhibited an accumulation pattern in all the 11 regions. K1 of 11C-SA4503 correlated with rCBF, but the other three rate constant parameters and BP did not. The regional difference in the BP of 11C-SA4503 is compatible with those of sigma1 receptors. In conclusion, successive PET measurements of rCBF and the brain kinetics of radioligand-neuroreceptor binding are useful for the first clinical trial of a newly developed radioligand for mapping neuroreceptors, and the protocol is applicable to pathophysiological studies of brain disorders.


11C-SA4503 Sigma1 receptors Cerebral blood flow PET 


  1. 1.
    Carson RE. Interpretation of model rate constants. In: Valk PE, Bailey DL, Townsend DW, Maisey MN, editors. Positron emission tomography: basic science and clinical practice. London: Springer; 2003. p. 153–155.Google Scholar
  2. 2.
    Su TP. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit Rev Neurobiol 1993;7:187–203.PubMedGoogle Scholar
  3. 3.
    Su TP, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 2003;10:2073–2080.PubMedCrossRefGoogle Scholar
  4. 4.
    Junien JL, Leonard BE. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance. Clin Neuropharmacol 1989;12:353–374.PubMedCrossRefGoogle Scholar
  5. 5.
    Mach RH, Smith CR, al-Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 1997;57:156–161.PubMedGoogle Scholar
  6. 6.
    Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000;82:1223–1232.PubMedCrossRefGoogle Scholar
  7. 7.
    Hashimoto K, Ishiwata K. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 2006;12:3857–3876.PubMedCrossRefGoogle Scholar
  8. 8.
    Kawamura K, Ishiwata K, Tajima H, Ishii S, Matsuno K, Homma Y, et al. In vivo evaluation of [11C]SA4503 as a PET ligand for mapping CNS sigma1 receptors. Nucl Med Biol 2000;27:255–2561.PubMedCrossRefGoogle Scholar
  9. 9.
    Kawamura K, Ishiwata K, Shimada Y, Kimura Y, Kobayashi T, Matsuno K, et al. Preclinical evaluation of [11C]SA4503: radiation dosimetry, in vivo selectivity and PET imaging of sigma1 receptors in the cat brain. Ann Nucl Med 2000;14:285–292.PubMedCrossRefGoogle Scholar
  10. 10.
    Kawamura K, Kimura Y, Tsukada H, Kobayashi T, Nishiyama S, Kakiuchi T, et al. An increase of sigma1 receptors in the aged monkey brain. Neurobiol Aging 2003;24;745–752.PubMedCrossRefGoogle Scholar
  11. 11.
    Sakata M, Kimura Y, Naganawa M, Oda K, Ishii K, Chihara K, et al. Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503. Neuroimage 2007;35:1–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Ishiwata K, Oda K, Sakata M, Kimura Y, Kawamura K, Oda K, et al. A feasible study of [11C]SA4503-PET for evaluating sigma1 receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors. Ann Nucl Med 2006;20:569–573.PubMedGoogle Scholar
  13. 13.
    Ishikawa M, Ishiwata K, Ishii K, Kimura Y, Sakata M, Naganawa M, et al. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a PET study using [11C]SA4503. Biol Psychiatry 2007;62:878–883.PubMedCrossRefGoogle Scholar
  14. 14.
    Mishina M, Ishiwata K, Ishii K, Kitamura S, Kimura Y, Kawamura K, et al. Function of sigma1 receptors in Parkinson’s disease. Acta Neurol Scand 2005;112:103–107.PubMedCrossRefGoogle Scholar
  15. 15.
    Mishina M, Ohyama M, Ishii K, Kitamura S, Kimura Y, Oda K, et al. Low density of sigma1 receptors in early Alzheimer’s disease. Ann Nucl Med 2008;22:151–156.PubMedCrossRefGoogle Scholar
  16. 16.
    Sakata M, Kimura Y, Naganawa M, Ishikawa M, Oda K, Ishii K, et al. Shortened protocol in practical [11C]SA4503-PET studies for the sigma1 receptor quantification. Ann Nucl Med 2008;22:143–146.PubMedCrossRefGoogle Scholar
  17. 17.
    Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K. Design and evaluation of HEADTOME-IV: a whole-body positron emission tomograph. IEEE Trans Nucl Sci 1989;36:1006–1010.CrossRefGoogle Scholar
  18. 18.
    Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with intravenous H2 15O: I. Theory and error analysis. J Nucl Med 1983;24:782–789.PubMedGoogle Scholar
  19. 19.
    Mishina M, Senda M, Kimura Y, Toyama H, Ishiwata K, Ohyama M, et al. Intrasubject correlation between static scan and distribution volume images for [11C]flumazenil PET. Ann Nucl Med 2000;14:193–198.PubMedGoogle Scholar
  20. 20.
    Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H. A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr 1995;19:615–623.PubMedCrossRefGoogle Scholar
  21. 21.
    Fukumitsu N, Ishii K, Kimura Y, Oda K, Sasaki T, Mori Y, et al. Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX. Ann Nucl Med 2003;17:511–515.PubMedGoogle Scholar
  22. 22.
    Shibuya H, Mori H, Toru M. Sigma receptors in schizophrenic cerebral cortices. Neurochem Res 1992;17:983–990.PubMedCrossRefGoogle Scholar
  23. 23.
    Mash DC, Zabetian CP. Sigma receptors are associated with cortical limbic areas in the primate brain. Synapse 1992;12:195–205.PubMedCrossRefGoogle Scholar
  24. 24.
    Okuyama S, Chaki S, Yae T, Nakazato A, Muramatsu M. Autoradiographic characterization of binding sites for [3H]NE-100 in guinea pig brain. Life Sci 1995;57:PL333–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Bouchard P, Quirion R. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience 1997;76:467–477.PubMedCrossRefGoogle Scholar
  26. 26.
    Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma1 receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat 2000;20:375–387.PubMedCrossRefGoogle Scholar
  27. 27.
    Kimura Y, Naganawa M, Sakata M, Ishikawa M, Mishina M, Oda K, et al. Distribution volume as an alternative to the binding potential for sigma1 receptor imaging. Ann Nucl Med 2007;21:533–535.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Nuclear Medicine 2008

Authors and Affiliations

  • Kiichi Ishiwata
    • 1
  • Kenji Ishii
    • 1
  • Yuichi Kimura
    • 1
  • Kazunori Kawamura
    • 1
  • Keiichi Oda
    • 1
  • Toru Sasaki
    • 1
  • Muneyuki Sakata
    • 1
  • Michio Senda
    • 1
    • 2
  1. 1.Positron Medical CenterTokyo Metropolitan Institute of GerontologyTokyoJapan
  2. 2.Institute of Biomedical Research and InnovationKobeJapan

Personalised recommendations